title: Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
authors.affiliation: Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors.forename: Lillian L
authors.initials: LL
authors.lastname: Emlet
authors.forename: David
authors.initials: D
authors.lastname: Crippen
mesh_terms: D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000401:mortality*; D015942:Factor VIIa / Q000627:therapeutic use*; D006406:Hematoma / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000401:mortality*; D016896:Treatment Outcome
chemical_list: D015942:Factor VIIa